EbixCash Plans To File IPO For As Much As $500 Million This Year, 

EbixCash plans to file for a $400 million-$500 million India IPO before the end of the year, IFR reported, citing people with knowledge of the transaction it did not identify.

Equirus, Motilal Oswal, SBI Capital Markets, Yes Securities have joined ICICI Securities in the IPO syndicate.

Glenmark Launches Fabispray For Treatment Of Adult Patients With Covid-19

Glenmark launches Nitric Oxide nasal spray (Fabispray) in India for the treatment of adult patients with Covid-19, in partnership with Canadian firm SaNOtize.

  • Glenmark had earlier received manufacturing and marketing approval from the Drugs Controller of India, for the nasal spray.
  • Fabispray has proven anti-microbial properties with a direct virucidal effect on SARS-CoV-2.

Source: Exchange Filing

In Focus: Vaccine Stocks On Pfizer’s Covid Sales Forecast Miss

Vaccine stocks in focus after Pfizer Inc. issued revenue guidance for its Covid-19 jab and pill that fell short of analyst expectations.

  • In Focus: Dr. Reddy’s Laboratories, Cadila Healthcare, Pfizer Ltd. (a unit of Pfizer Inc.)

Analyst Actions: Thermax, Sundaram Finance

  • Thermax cut to ‘neutral’ by Credit Suisse; price target set at Rs 1,900.
  • Sundaram Finance upgraded to ‘add’ from ‘reduce’ by Spark Capital Advisors; price target set at Rs 2,447.

Source: Bloomberg

Sensex, Nifty gain in pre-opening session on Wednesday

BSE Sensex jumped 400 points to trade above 58200, while Nifty 50 index gained 130 points at 17396 in the pre-opening session

Sensex, Nifty jump over 0.5% in opening deals

BSE Sensex jumped 400 points to trade above 58229, while Nifty 50 index reclaimed 17350

Spread the love

Neal Bhai has been involved in the Bullion and Metals markets since 1998 – he has experience in many areas of the market from researching to trading and has worked in Delhi, India. Mobile No. - 9899900589 and 9582247600

Leave a Comment